참고문헌
- Abediankenari S, Ghasemi M, Nasehi MM, Abedi S, Hosseini V (2011). Determination of trace elements in patients with chronic Hepatitis B. Acta Medica Iranica, 49, 667-669.
- Abediankenari S, Janbabaei Mollae G, Ghasemi M, et al (2013).Vaccination of diffuse large B-cell lymphoma patients with antigen-primed dendritic cells. Acta Medica Iranica, 51, 284-288.
- Abediankenari S, Yousefzadeh Y, Azadeh H, Vahedi M (2010). Comparision of several maturation inducing factors indendritic cell differentiation. Iran J Immunol, 7, 83-87.
- Arap MA (2005). Phage display technology - Applications and innovations. Genet Mol Biol, 1, 1-9.
- Bahadir AO, Balcioglu BK, Uzyol KS, et al (2011). Phagedisplayed HBV core antigen with immunogenic activity. Appl Biochem Biotechnol, 165, 1437-47. https://doi.org/10.1007/s12010-011-9365-1
- Bakhshinejad B, Sadeghizadeh M (2014). Bacteriophages asvehicles for gene delivery into mammalian cells: prospects and problems. Expert Opin Drug deliv, 11.
- Bazan J, Calkosi.ski I, Gamian A (2012). Phage display.Apowerful technique for immunotherapy. Hum Vaccin Immunother, 8, 1829-35. https://doi.org/10.4161/hv.21704
- Bratkovic T (2010). Progress in phage display: evolution of the technique and its applications. Cell Mol Life Sci, 67, 749-67. https://doi.org/10.1007/s00018-009-0192-2
- Bruttin A, Brussow H (2005). Human volunteers receivingEscherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother, 49, 2874-8. https://doi.org/10.1128/AAC.49.7.2874-2878.2005
- Clark JR, March JB (2004). Bacteriophage-mediated nucleic acidimmunization. FEMS Immunol Med Microbiol, 40, 21-26. https://doi.org/10.1016/S0928-8244(03)00344-4
- Clark JR, March JB (2006). Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol, 24, 212-8. https://doi.org/10.1016/j.tibtech.2006.03.003
- Cortese R, Felici F, Galfre G, et al (1994). Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol, 12, 262-7. https://doi.org/10.1016/0167-7799(94)90137-6
- Cuesta A M, Suarez E, Larsen M, et al (2006). Enhancement of DNA vaccine potency through linkage of antigen tofilamentous bacteriophage coat protein III domain I. Immunology, 117, 502-6. https://doi.org/10.1111/j.1365-2567.2006.02325.x
- De Berardinis P, Sartorius R, Fanutti C, et al (2000). Phagedisplay of peptide epitopes from HIV-1 elicits strongcytolytic responses. Nat Biotechnol, 18, 873-6. https://doi.org/10.1038/78490
- de la Cruz VF, Lal AA, McCutchan TF (1988). Immumogenicityand epitope mapping of foreign sequences via genetically engineered filamentous phage. J Biol Chem, 263, 4318-22.
- Delmastro P, Meola A, Monaci P, Cortese R, Galfre G (1997). Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine, 15, 1276-85. https://doi.org/10.1016/S0264-410X(97)00072-8
- Eguchi A, Akuta T, Okuyama H, et al (2001). Protein transductiondomain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem, 276, 26204-10. https://doi.org/10.1074/jbc.M010625200
- Fack F, Hugle-Dorr B, Song D, et al (1997). Epitope mapping by phage display: random versus gene-fragment libraries. J Immunol Methods, 206, 43-52. https://doi.org/10.1016/S0022-1759(97)00083-5
- Fang J, Wang G, Yang Q, et al (2005). The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine, 23, 4860-6. https://doi.org/10.1016/j.vaccine.2005.05.024
- Gamage LNA, Ellis J, Hayes S, et al (2009). Immunogenicity of bacteriophage lambda particles displaying porcineCircovirus 2 (PCV2) capsid protein epitopes. Vaccine, 27,6595-604. https://doi.org/10.1016/j.vaccine.2009.08.019
- Gao J, Liu Z, Huang M, Li X, Wang Z (2011). T7 phagedisplaying latent membrane protein 1 of Epstein-Barr virus elicits humoral and cellular immune responses in rats. Acta Virol, 55, 117-21. https://doi.org/10.4149/av_2011_02_117
- Gao J, Wang Y, Liu Z. Wang Z (2010). Phage display and its application in vaccine design. Ann Microbiol, 60, 13-19. https://doi.org/10.1007/s13213-009-0014-7
- Gaubin M, Fanutti C, Mishal Z, et al (2003). Processing offilamentous bacteriophage virions in antigen-presentingcells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol, 22, 11-18. https://doi.org/10.1089/104454903321112451
-
Ghaemi A, Soleimanjehi H, Gill P, et al (2010). Recombinant
$\lambda$ -phage nanobioparticles for tumor therapy in mice models. Genet Vaccines Ther, 8(3). - Hashemi H, Pouyanfard S, Bandehpour M, et al (2012).Immunization with M2e-displaying T7 bacteriophagenanoparticles protects against influenza A virus vhallenge. PLOS ONE, 7, 1-11.
- Hayes S, Gamage NA, Hayes C (2010). Dual expression systemfor assembling phage lambda display particle (LDP) vaccineto porcine Circovirus 2 (PCV2). Vaccine, 28, 6789-99. https://doi.org/10.1016/j.vaccine.2010.07.047
- Irving MB, Pan O, Scott JK (2001). Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol, 5, 314-24. https://doi.org/10.1016/S1367-5931(00)00208-8
- Ivanenkov VV, Felici F, Menon AG (1999). Uptake andintracellular fate of phage display vectors in mammalian cells. Biochim et Biophys Acta, 1448, 450-62. https://doi.org/10.1016/S0167-4889(98)00162-1
- Jepson CD, March JB (2004). Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine, 22, 2413-19. https://doi.org/10.1016/j.vaccine.2003.11.065
- Jiang J, Abu-Shilbayeh L, Rao BV (1997). Display of a PorApeptide from Neisseria meningitidis on the bacteriophage T4 capsid surface. Infect Immun, 65, 4770-77.
- Kaur T, Nafissi N, Wasfi O, et al (2012). Immunocompatibility of Bacteriophages as Nanomedicines. J Nanotechnol, 1-13.
- Khalaj-Kondori M, Sadeghizadeh M, Behmanesh M, Saggio I, Monaci P (2011). Chemical coupling as a potent strategy for preparation of targeted bacteriophage-derived genenanocarriers into eukaryotic cells. J Gene Med, 13, 622-31. https://doi.org/10.1002/jgm.1617
- Kim A, Shin TH, Shin SM, et al (2012). Cellular internalization mechanism and intracellular trafficking of filamentous M13phages displaying a cell penetrating transbody and TATpeptide. PLOS ONE, 7, 1-14.
- Knittelfelder R, Riemer AB, Jensen-Jarolim E, (2009). Mimotope vaccination . from allergy to cancer. Expert Opin Biol Ther, 9, 493-506. https://doi.org/10.1517/14712590902870386
- Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R (1999). Identification of receptor ligands with phage displaypeptide libraries. J Nucl Med, 40, 883-8.
- Lankes HA, Zanghi CN, Santos K, et al (2007). In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol, 102, 1337-49. https://doi.org/10.1111/j.1365-2672.2006.03182.x
- Li W, Joshi MD, Singhania S, Ramsey KH, Murthy AK (2014). Peptide vaccine: progress and challenges. Vaccines, 2,515-36. https://doi.org/10.3390/vaccines2030515
- Loessner MJ, Rudolf M, Scherer S (1997). Evaluation ofluciferase reporter bacteriophage A511::luxAB for detectionof Listeria monocytogenes in contaminated foods. Appl Environ Microbiol, 63, 2961-5.
- Luzzago A, Felici F, Tramontano A, Pessi A, Cortese R (1993). Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene, 128, 51-57. https://doi.org/10.1016/0378-1119(93)90152-S
- Malik P, Perham RN (1997). Simultaneous display of different peptides on the surface of filamentous bacteriophage. Nucleic Acids Res, 25, 915-6. https://doi.org/10.1093/nar/25.4.915
- Manoutcharian K, Diaz-Orea A, Gevorkian G, et al (2004).Recombinant bacteriophage-based multiepitope vaccineagainst Taenia solium pig cysticercosis. Vet Immunol Immunopathol, 99, 11-24. https://doi.org/10.1016/j.vetimm.2003.12.009
- Manoutcharian K, Terrazas LI, Gevorkian G, et al (1999). Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effectivevaccine design tested in murine cysticercosis. Infect Immun, 67, 4764-4770.
-
March JB, Clark JR, Jepson CD (2004). Genetic immunization against hepatitis B using whole bacteriophage
$\lambda$ particles. Vaccine, 22, 1666-71. https://doi.org/10.1016/j.vaccine.2003.10.047 - Meij P, Leen A, Rickinson AB, et al (2002a). Identification and prevalence of CD8+ T-cell responses directed against Epstein-Bar virus-encoded latent membrane protein 1 and latent membrane protein 2. Int J Cancer, 99, 93-99. https://doi.org/10.1002/ijc.10309
- Meij P, Vervoort MBHJ, Bloemena E, et al (2002b). Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. J Med Virol, 68, 370-377. https://doi.org/10.1002/jmv.10213
- Menendez T, Santiago-Vispo NF, Cruz-Leal Y, et al (2011).Identification and characterization of phage-displayedpeptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide. Int J Med Microbiol, 301, 16-25. https://doi.org/10.1016/j.ijmm.2010.04.020
- Moingeon P, de Taisne C, Almond J (2002). Delivery technologies for human vaccines. Br Med Bull, 62, 29-44. https://doi.org/10.1093/bmb/62.1.29
- Neufeld T, Schwartz-Mittelmann A, Biran D, Ron EZ, Rishpon J(2003). Combined phage typing and amperometric detection of released enzymatic activity for the specific identification and quantification of bacteria. Anal Chem, 75, 580-5. https://doi.org/10.1021/ac026083e
- Odermatt A, Audige A, Frick C, et al (2001). Identification of receptor ligands by screening phage display peptide librariesex vivo on microdissected kidney tubules. J Am Soc Nephrol, 12, 308-16.
- Ou C, Tian D, Ling Y, et al (2013). Evaluation of an ompA-based phage-mediated DNA vaccine against Chlamydia abortusin piglets. Int immunopharmacol, 16, 505-10. https://doi.org/10.1016/j.intimp.2013.04.027
- Pande J, Szewczyk MM, Grover, AK (2010). Phage display: Concept, innovations, applications and future. Biotechnol Adv, 28, 849-58. https://doi.org/10.1016/j.biotechadv.2010.07.004
- Petrovsky N, Aguilar JC (2004). Vaccine adjuvants: Current stateand future trends. Immunol cell Biol, 82, 488-96. https://doi.org/10.1111/j.0818-9641.2004.01272.x
- Purcell AW, McCluskey J, Rossjohn J (2007). More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Disc, 6, 404-414. https://doi.org/10.1038/nrd2224
- Ren SX, Ren ZJ, Zhao MY, et al (2009). Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface. Acta Pharmacol Sin, 30, 637-45. https://doi.org/10.1038/aps.2009.44
- Sartorius R, Pisu P, Apice LD, et al (2008). The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLAA2-restricted peptides and to induce strong antitumor CTL responses. J Immunol, 180, 3719-28. https://doi.org/10.4049/jimmunol.180.6.3719
- Saxena MV, M, Van TTH, Baird FJ, Coloe PJ, Smooker PM (2013). Pre-existing immunity against vaccine vectors -friend or foe? Microbiol, 159, 1-11. https://doi.org/10.1099/mic.0.049601-0
- Schmelcher M, Loessner MJ (2014). Application of bacteriophages for detection of foodborne pathogens. Bacteriophage, 4.
- Smith G P (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315-7. https://doi.org/10.1126/science.4001944
- Souza APD, Haut L, Reyes-Sandoval A, Pinto, AR (2005). Recombinant viruses as vaccines against viral diseases. Brazi J Med Biol Res, 38, 509-22. https://doi.org/10.1590/S0100-879X2005000400004
- Ulivieri C, Citro A, Ivaldi F, et al (2008). Antigenic properties of HCMV peptides displayed by filamentous bacteriophagesvs. synthetic peptides. Immunol Lett, 119, 62-70. https://doi.org/10.1016/j.imlet.2008.04.004
- van Houten NE, Henry KA, Smith GP, Scott JK (2010).Engineering filamentous phage carriers to improve focusingof antibody responses against peptides. Vaccine, 28, 2174-2185. https://doi.org/10.1016/j.vaccine.2009.12.059
- van Houten NE, Zwick MB, Menendez A, Scott JK (2006). Filamentous phage as an immunogenic carrier to elicitfocused antibody responses against a synthetic peptide.Vaccine, 24, 4188-200. https://doi.org/10.1016/j.vaccine.2006.01.001
- Wan Y, Yuzhang Y, Bian J, et al (2001). Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine, 19, 2918-23. https://doi.org/10.1016/S0264-410X(00)00561-2
- Wan Y, Wu Y, Zhou J, et al (2005). Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments. Eur J Immunol, 35, 2041-50. https://doi.org/10.1002/eji.200425322
- Wang G, Sun M, Fang J, et al (2006). Protective immuneresponses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine, 24, 6065-6073. https://doi.org/10.1016/j.vaccine.2006.05.022
- Wang LF, Yu M (2004). Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets, 5, 1-15.
- Wang Y, Su Q, Dong S, et al (2014). Hybrid phage displaying SLAQVKYTSASSI induces protection against Candidaalbicans challenge in BALB/c mice. Hum Vaccin Immunother, 10, 1057-63. https://doi.org/10.4161/hv.27714
- Willis AE, Perham RN, Wraith D (1993). Immunological properties of foreign peptides in multiple display on afilamentous bacteriophage. Gene, 128, 79-83. https://doi.org/10.1016/0378-1119(93)90156-W
- Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994). Making antibodies by phage display technology. Annu Rev Immunol, 12, 433-55. https://doi.org/10.1146/annurev.iy.12.040194.002245
- Wright A, Hawkins CH, Anggard EE, Harper DR (2009). A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol, 34, 349-57. https://doi.org/10.1111/j.1749-4486.2009.01973.x
- Wu Y, Wan Y, Bian J, et al (2002). Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine P815 model. Int J Cancer, 98, 748-53. https://doi.org/10.1002/ijc.10260
- Yang J, Li Y, Jin S, et al (2015). Engineered biomaterials for development of nucleic acid vaccines. Biomater Res, 19.
- Yokoyama-Kobayashi M, Kato S (1994). Recombinant f1 phage-mediated transfection of mammalian cells using lipopolyamine technique. Anal Biochem, 223, 130-134. https://doi.org/10.1006/abio.1994.1557
피인용 문헌
- MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell vol.39, pp.5, 2017, https://doi.org/10.1177/1010428317701652
- The viral approach to breast cancer immunotherapy vol.234, pp.2, 2018, https://doi.org/10.1002/jcp.27150
- A Novel Molecular Design for a Hybrid Phage-DNA Construct Against DKK1 vol.60, pp.11, 2018, https://doi.org/10.1007/s12033-018-0115-2